News

After Pear Therapeutics' bankruptcy, experts warn that more failures are coming for the digital-therapeutics industry. Menu icon A vertical stack of three evenly spaced horizontal lines.
Why turn to digital therapeutics. Many of the advantages of digital therapeutics are self-evident due to the way they are delivered, in the form of a smartphone or device.
Medicare’s physician fee schedule includes billing codes for digital therapeutics for the first time. Stakeholders say these codes could help turn around reimbursement challenges weighing on the ...
As the digital therapeutics industry deals with a lack of reimbursement pathways, companies like Akili Interactive are taking alternate approaches to growth.
Last updated June 11, 1:47 p.m. | The Digital Therapeutics Alliance announced a partnership with DirectTrust to start an accreditation program for digital therapeutics products to help gain uptake ...
The Digital Therapeutics Alliance's annual conference kicked off Wednesday in Washington, D.C. The conference aims to bring together providers, payers, companies and regulatory agencies to discuss ...
Digital therapeutics could be a shot in the arm for overstretched and underfunded health services. But, for digital therapeutics to succeed in alleviating and modernizing healthcare, clinical and ...
Digital therapeutics (DTx), software-based interventions for health disorders or diseases, are gaining traction. The rise in digital tools usage has increased the demand for digital therapeutics.
And prescription digital therapeutics are the essential ingredient in the AI-enablement of pharma’s future: They are how pharma wins the race to bring AI to patient care.
But Better and Akili’s 2023 struggles pale in comparison to those of Pear Therapeutics. Following two rounds of layoffs last year, Pear—whose reSET app for substance use disorder became the ...
After Pear Therapeutics' bankruptcy, experts warn that more failures are coming for the digital-therapeutics industry. Business Insider Subscribe Newsletters ...